Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Bing Chen Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0026-1249; OpenAlex author ID A5100443091. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Mitochondria-Targeting Virus-Like Gold Nanoparticles Enhance Chemophototherapeutic Efficacy Against Pancreatic Cancer in a Xenograft Mouse Model. Last author DOI 10.2147/ijn.s497346↗
  2. Comprehensive analysis of the prognosis of S100 family members and their relationship with tumor-infiltrating immune cells in human pancreatic adenocarcinoma. First author DOI 10.1097/md.0000000000032976↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Feng Xu · 1 shared paper, 2023 · strength 0.26
  2. Yajun Ren · 1 shared paper, 2023 · strength 0.26
  3. Ronggui Lin · 1 shared paper, 2024 · strength 0.19
  4. Tianhong Teng · 1 shared paper, 2024 · strength 0.19
  5. Yanbin Meng · 1 shared paper, 2024 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.